Pharmaceutics (Oct 2021)

Essential Oils of <i>Melaleuca, Citrus</i>, <i>Cupressus</i>, and <i>Litsea</i> for the Management of Infections Caused by <i>Candida</i> Species: A Systematic Review

  • Rafael Alves da Silva,
  • Flávia Maria Pinto Monteiro Antonieti,
  • Denise Von Dolinger de Brito Röder,
  • Reginaldo dos Santos Pedroso

DOI
https://doi.org/10.3390/pharmaceutics13101700
Journal volume & issue
Vol. 13, no. 10
p. 1700

Abstract

Read online

Candida is a common agent of infection in humans, which has a wide distribution and is a colonizer fungus of the body, occasionally assuming the role of a pathogen. The type of treatment depends on the site of infection and the clinical condition of the patient. Superficial infections, such as mucosal infections, can be treated with topical medications. So-called alternative therapies have rarely been studied, although the literature records the effectiveness of some treatments, especially as complementary therapy. The aims of this review were to analyze evidence of the anti-Candida inhibitory activity of essential oils of the Citrus, Cupressus, Litsea, and Melaleuca species; in addition to addressing the chemical composition, probable mechanisms of antifungal action and studies of toxicity, cytotoxicity, and genotoxicity were included. The literature from Medline/PubMed, Science Direct, Scopus, Web of Science, and the Brazilian database Periodic Capes was reviewed. Thirty-eight articles were selected, which included two articles on Litsea spp., seven on Cupressus spp., thirteen articles on Citrus spp., and twenty-one articles on Melaleuca spp. In conclusion, this study showed in vitro evidence for the use of essential oils of the plant species evaluated for the treatment of infections caused by different Candida species.

Keywords